- Home
- WKHS vs MAIA Comparison
WKHS vs MAIA Comparison
Compare WKHS & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKHS
- MAIA
- Stock Information
- Founded
- WKHS 2007
- MAIA 2018
- Country
- WKHS United States
- MAIA United States
- Employees
- WKHS N/A
- MAIA N/A
- Industry
- WKHS Auto Manufacturing
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- WKHS Consumer Discretionary
- MAIA Health Care
- Exchange
- WKHS Nasdaq
- MAIA Nasdaq
- Market Cap
- WKHS 6.0M
- MAIA 46.7M
- IPO Year
- WKHS N/A
- MAIA 2022
- Fundamental
- Price
- WKHS $4.42
- MAIA $1.88
- Analyst Decision
- WKHS Hold
- MAIA
- Analyst Count
- WKHS 1
- MAIA 0
- Target Price
- WKHS $15.62
- MAIA N/A
- AVG Volume (30 Days)
- WKHS 6.6M
- MAIA 529.1K
- Earning Date
- WKHS 08-19-2025
- MAIA 08-08-2025
- Dividend Yield
- WKHS N/A
- MAIA N/A
- EPS Growth
- WKHS N/A
- MAIA N/A
- EPS
- WKHS N/A
- MAIA N/A
- Revenue
- WKHS $5,917,985.00
- MAIA N/A
- Revenue This Year
- WKHS $54.16
- MAIA N/A
- Revenue Next Year
- WKHS $85.00
- MAIA N/A
- P/E Ratio
- WKHS N/A
- MAIA N/A
- Revenue Growth
- WKHS N/A
- MAIA N/A
- 52 Week Low
- WKHS $0.81
- MAIA $1.40
- 52 Week High
- WKHS $28.13
- MAIA $4.24
- Technical
- Relative Strength Index (RSI)
- WKHS 95.23
- MAIA 56.41
- Support Level
- WKHS $2.52
- MAIA $1.80
- Resistance Level
- WKHS $3.89
- MAIA $2.15
- Average True Range (ATR)
- WKHS 0.53
- MAIA 0.13
- MACD
- WKHS 0.31
- MAIA 0.02
- Stochastic Oscillator
- WKHS 74.57
- MAIA 60.00
About WKHS Workhorse Group Inc.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.